A Case of <scp>AQP4</scp> Antibody–Positive <scp>NMOSD</scp> Initially Manifesting as Extensive, Asymptomatic Cerebral White Matter Lesions and Subsequently Developing Cognitive Impairment

ABSTRACT Background The original diagnostic criteria for neuromyelitis optica (NMO) required both optic neuritis and myelitis. The subsequent recognition of cases with either one of these features or other central nervous system lesions, including brain involvement, gave rise to the concept of NMO spectrum disorder (NMOSD). Cerebral involvement has been reported in various forms, including extensive lesions, asymptomatic lesions, and cases in which brain pathology represents the initial clinical manifestation. Despite this, asymptomatic individuals are not currently included within the 2015 NMOSD diagnostic criteria. Case Presentation A 74‐year‐old man was referred to our hospital due to abnormal findings on brain MRI, despite the absence of neurological deficits. Brain magnetic resonance imaging (MRI) demonstrated multifocal extensive cerebral white matter lesions with multiple ill‐defined, patchy, mild, and irregular gadolinium‐enhancing lesions, consistent with “cloud‐like enhancement.” Aquaporin‐4 (AQP4) antibodies were negative by enzyme‐linked immunosorbent assay (ELISA) but positive on a cell‐based assay (CBA). At that time, the patient was asymptomatic and therefore did not meet the diagnostic criteria for NMOSD. After exhaustive exclusion of alternative diagnoses and the subsequent development of cognitive impairment, the patient was diagnosed with NMOSD. Conclusions To our knowledge, this is the first reported case in which extensive, asymptomatic cerebral white matter lesions served as the initial manifestation of NMOSD, emphasizing the clinical importance of considering such cases in the differential diagnosis, evaluating appropriate treatment strategies, and potentially informing future revisions of the NMOSD diagnostic criteria.

Institutions

Publication Details

Journal
Clinical and Experimental Neuroimmunology
Published
2025-12-08
DOI
https://doi.org/10.1111/cen3.70041
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Case of AQP4 Antibody–Positive NMOSD Initially Manifesting as Extensive, Asymptomatic Cerebral White Matter Lesions and Subsequently Developing Cognitive Impairment

Clinical and Experimental Neuroimmunology
Multiple Sclerosis Research Studies
article

A Case of AQP4 Antibody–Positive NMOSD Initially Manifesting as Extensive, Asymptomatic Cerebral White Matter Lesions and Subsequently Developing Cognitive Impairment

article en

Abstract

ABSTRACT Background The original diagnostic criteria for neuromyelitis optica (NMO) required both optic neuritis and myelitis. The subsequent recognition of cases with either one of these features or other central nervous system lesions, including brain involvement, gave rise to the concept of NMO spectrum disorder (NMOSD). Cerebral involvement has been reported in various forms, including extensive lesions, asymptomatic lesions, and cases in which brain pathology represents the initial clinical manifestation. Despite this, asymptomatic individuals are not currently included within the 2015 NMOSD diagnostic criteria. Case Presentation A 74‐year‐old man was referred to our hospital due to abnormal findings on brain MRI, despite the absence of neurological deficits. Brain magnetic resonance imaging (MRI) demonstrated multifocal extensive cerebral white matter lesions with multiple ill‐defined, patchy, mild, and irregular gadolinium‐enhancing lesions, consistent with “cloud‐like enhancement.” Aquaporin‐4 (AQP4) antibodies were negative by enzyme‐linked immunosorbent assay (ELISA) but positive on a cell‐based assay (CBA). At that time, the patient was asymptomatic and therefore did not meet the diagnostic criteria for NMOSD. After exhaustive exclusion of alternative diagnoses and the subsequent development of cognitive impairment, the patient was diagnosed with NMOSD. Conclusions To our knowledge, this is the first reported case in which extensive, asymptomatic cerebral white matter lesions served as the initial manifestation of NMOSD, emphasizing the clinical importance of considering such cases in the differential diagnosis, evaluating appropriate treatment strategies, and potentially informing future revisions of the NMOSD diagnostic criteria.

Clinical and Experimental NeuroimmunologyVol. 17(1)
Osaka University of Pharmaceutical Sciences (JP)
Openalex Percentile: Top 33%
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Case of <scp>AQP4</scp> Antibody–Positive <scp>NMOSD</scp> Initially Manifesting as Extensive, Asymptomatic Cerebral White Matter Lesions and Subsequently Developing Cognitive Impairment · Clinical and Experimental Neuroimmunology (2025) | TGRS Research Map | TGRS